Rheumatology
Rheumatology is a branch of medicine devoted to the diagnosis and therapy of rheumatic diseases. Clinicians who have undergone formal training in rheumatology are called rheumatologists.
A chronic inflammatory disorder affecting many joints, including those in the hands and feet.In rheumatoid arthritis, the body's immune system attacks its own tissue, including joints. In severe cases, it attacks internal organs.Rheumatoid arthritis affects joint linings, causing painful swelling. Over long periods of time, the inflammation associated with rheumatoid arthritis can cause bone erosion and joint deformity.
While there's no cure for rheumatoid arthritis, physiotherapy and medication can help slow the disease's progression. Most cases can be managed with a class of medications called anti-rheumatic drugs (DMARDS), Oral JAK inhibitors & Biologicals
Factors, which increases the risk of RA
- Sex : Woman are more likely then Men to develop RA, Female to Male ratio 3:1
- Age : RA can strike at any age RA generally starts in women between the ages of 30 to 60
- Family history : If a family member has RA, you may have an increased risk of the disease
- Smoking : increases risk of developing RA
- Environmental exposure
- Obesity : Especially woman age 55 & younger- who are overweight has high risk of developing RA
RA Requires a medical diagnosis
Rheumatoid arthritis affects joint linings, causing painful swelling. Over long periods, the inflammation associated with rheumatoid arthritis can cause bone erosion and joint deformity. RA can’t be cured, but Your Clinician will do definitive diagnosis & initiate right treatment. RA symptoms are completely treatable when your clinician initiates early treatment with anti-rheumatic drugs DMARDS, Oral JAK inhibitors & Biologicals Alkem realized the silent need of the society & took
Early initiatives...
To create social awareness about the silent disease - with the help of various patient educational media- Patient education leaflets, posters, newspaper articles, patient educational meets.
For disease diagnosis - To pin down disease at an early stage, Alkem organized various RA detection camps across vast geographical areas across India at Rural, District & Metro city level.
For stopping the Disease progression - For patients with Immunomodulatory diseases like severe RA , Alkem entered into biosimilar segment &introduced brands like MABVINRA injection (Adalimumab). Alkem entered into biosimilar segment &introduced brands like MABVINRA injection (Adalimumab), 1st time in India JAK inhibitor TOFE (Tofacitinib 5mg) oral tablets & the most recently Denu ( Denosumab 60mg/ml Inj ) for subcutaneous use once in 6 months
With strategic initiatives & foresight, Alkem is continuously innovating & working in the direction of Rheumatoid Arthritis – Awareness, diagnosis & management
